Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Irina Mihaela Cazacu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7483-7194; OpenAlex author ID A5036267046. Sources: OpenAlex.

Their work

Papers
18 (first author 7, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
57
Papers, trials and grants by year

2018: 1 paper · 2019: 5 papers · 2020: 4 papers · 2021: 2 papers · 2022: 4 papers · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 18

  1. Fatty pancreas on EUS: Risk factors, correlation with CT/MRI, and implications for pancreatic cancer screening. Co-author DOI 10.1097/eus.0000000000000109↗
  2. Endoscopic Ultrasound-Guided Fiducial Placement for Stereotactic Body Radiation Therapy in Patients with Pancreatic Cancer. Co-author DOI 10.3390/cancers15225355↗
  3. Precision Oncology With Germline and Somatic Sequencing in Pancreatic Cancer: The Time Is Now. Co-author DOI 10.1097/mpa.0000000000002026↗
  4. Quantitative contrast-enhanced endoscopic ultrasound in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine tumors: can we predict survival using pe… First author DOI 10.11152/mu-3503↗
  5. Evaluation of MMR Status and PD-L1 Expression Using Specimens Obtained by EUS-FNB in Patients with Pancreatic Ductal Adenocarcinoma (PDAC). Co-author DOI 10.3390/diagnostics12020294↗
  6. Diagnostic Value of Artificial Intelligence-Assisted Endoscopic Ultrasound for Pancreatic Cancer: A Systematic Review and Meta-Analysis. Co-author DOI 10.3390/diagnostics12020309↗
  7. Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pancreatic Cancer. Co-author DOI 10.1016/j.adro.2020.11.006↗
  8. Prognostic biomarkers related to tumoral microenvironment in pancreatic ductal adenocarcinoma: a systematic review. First author DOI 10.47162/rjme.62.3.03↗
  9. Endoscopic Ultrasound-Guided Treatment of Pancreatic Cancer. Co-author DOI 10.1007/s11894-020-00767-1↗
  10. Upfront molecular profiling of pancreatic cancer patients - An idea whose time has come. First author DOI 10.1016/j.pan.2020.01.017↗
  11. An open-label, single-arm pilot study of EUS-guided brachytherapy with phosphorus-32 microparticles in combination with gemcitabine +/- nab-paclitaxel in unres… Last author DOI 10.4103/eus.eus_44_19↗
  12. Quality of life impact of EUS in patients at risk for developing pancreatic cancer. First author DOI 10.4103/eus.eus_56_19↗
  13. Novel EUS-guided brachytherapy treatment of pancreatic cancer with phosphorus-32 microparticles: first United States experience. First author DOI 10.1016/j.vgie.2019.02.009↗
  14. EUS-guided placement of fiducial markers for the treatment of pancreatic cancer. Co-author DOI 10.1016/j.vgie.2019.05.007↗
  15. Changes in tumor vascularity depicted by contrast-enhanced EUS as a predictor of prognosis and treatment efficacy in patients with unresectable pancreatic canc… Co-author DOI 10.4103/eus.eus_16_19↗
  16. Psychological impact of pancreatic cancer screening by EUS or magnetic resonance imaging in high-risk individuals: A systematic review. First author DOI 10.4103/eus.eus_25_18↗
  17. Artificial intelligence in pancreatic cancer: Toward precision diagnosis. First author DOI 10.4103/eus.eus_76_19↗
  18. Pancreatitis-Associated Genes and Pancreatic Cancer Risk: A Systematic Review and Meta-analysis. Co-author DOI 10.1097/mpa.0000000000001145↗

Closest collaborators

The 25 strongest of 57 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Manoop S. Bhutani · 13 shared papers, 2019–2025 · strength 1.77
  2. Adrian Săftoiu · 9 shared papers, 2019–2025 · strength 1.29
  3. Alina Liliana Constantin · 4 shared papers, 2019–2022 · strength 0.54
  4. Joseph M. Herman · 5 shared papers, 2019–2023 · strength 0.52
  5. Matthew H. G. Katz · 4 shared papers, 2019–2025 · strength 0.49
  6. Cullen M. Taniguchi · 4 shared papers, 2019–2023 · strength 0.44
  7. Eugene Jon Koay · 4 shared papers, 2019–2023 · strength 0.42
  8. Albert C. Koong · 3 shared papers, 2019–2023 · strength 0.34
  9. Shubham Pant · 2 shared papers, 2019–2022 · strength 0.33
  10. Florencia M. McAllister · 2 shared papers, 2020–2025 · strength 0.33
  11. Bogdan Silviu Ungureanu · 2 shared papers, 2022 · strength 0.32
  12. Anirban Maitra · 2 shared papers, 2020 · strength 0.24
  13. Ramez M. Ibrahim · 1 shared paper, 2025 · strength 0.24
  14. Michael P. Kim · 1 shared paper, 2025 · strength 0.24
  15. Shalini Moningi · 2 shared papers, 2019–2021 · strength 0.20
  16. Emmanuel S. Coronel · 2 shared papers, 2019 · strength 0.17
  17. Stephen G. Chun · 1 shared paper, 2023 · strength 0.17
  18. Eric Peter Tamm · 2 shared papers, 2019–2020 · strength 0.16
  19. Robert A. Wolff · 2 shared papers, 2019–2020 · strength 0.16
  20. Gauri Rajani Varadhachary · 2 shared papers, 2019–2020 · strength 0.16
  21. David R. Fogelman · 2 shared papers, 2019–2020 · strength 0.16
  22. Elena Adriana Dumitrescu · 1 shared paper, 2022 · strength 0.15
  23. Cristian Virgil Lungulescu · 1 shared paper, 2022 · strength 0.15
  24. Michael Jon Pishvaian · 1 shared paper, 2020 · strength 0.15
  25. Daniela Tabacelia · 1 shared paper, 2022 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.